NCT03444220View on ClinicalTrials.gov

Gut Microbiota Transplantation in Systemic Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

May 18, 2018

Study Completion Date

October 15, 2018

Conditions
Scleroderma, Systemic
Interventions
BIOLOGICAL

Anaerobically Cultivated Human Intestinal Microbiota

30ml ACHIM will be administrated at week 0 and 2 with 14 days apart

BIOLOGICAL

Anaerobically Cultivated medium

30ml medium will be administrated at week 0 and 2 with 14 days apart

Trial Locations (1)

0372

Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT03444220 - Gut Microbiota Transplantation in Systemic Sclerosis | Biotech Hunter | Biotech Hunter